INTRODUCTION
In this report we describe two cases of 38 years old men sharing a similar medical history characterized by recent onset asthenia and mild effort dyspnea with a subsequent diagnosis of non-ischemic dilated cardiomyopathy. Based on the high prevalence of SDB in patients with cardiovascular disease and the well established relationship between SDB and HF in terms of risk factors and comorbidities, we decided to perform a cardio-respiratory sleep study in both patients. This examination established a diagnosis of sleeprelated disordered breathing with prevalent obstructivesleep apnea in only one of these patients, thus giving rise to a brief discussion about the complex pathophysiological relationships between HF and SDB.
Clinical case 1
A 38-years-old Caucasian man with no previous cardiovascular events and no risk factors presented to the Emergency Department of our hospital for new onset mild effort dyspnea. Physical examination revealed protodiastolic gallop rhythm and pulmonary basal crackles. A twelve lead ECG was recorded, showing sinus tachycardia (HR: 100 bpm), possible left atrial enlargement, left anterior fascicular block and some supraventricular ectopic beats (Figure 1 .A). The chest X-rays showed widened heart silhouette and Kerley's B lines. An echocardiogram revealed significant enlargement and severe dysfunction of the left ventricle (end diastolic diameter: 70 mm; LVEF < 20%), moderate mitral valve regurgitation due to annulus dilation, significant left atrial enlargement (258 ml). The patient was admitted to the Cardiology Unit and underwent blood sample ruling out the presence of acute viral infections.In particular, IgMs and IgAs for common cardiotropic and respiratory viruses were negative, including Echovirus, Coxsackievirus, Adenovirus, Parvovirus B19, Herpes Simplex Virus, Epstein-Barr Virus, Cytomegalovirus,Orthomyxovirus and Paramyxoviruses, as well as for Chlamydia and Rickettsia serum tests. The coronary angiography showed normal coronary arteries. A cardiac magnetic resonance evidenced severe biventricular dysfunction and enlargement and ruled out the presence of areas of edema and delayed enhancement (Figure 1.B) . Betablockers, ARBs (up-titrated to the highest tolerated doses) and diuretics were administered with clinical benefit and a primary prevention single-chamber implantable cardioverter-defibrillator was implanted three months later because of persistent low ejection fraction despite optimal medical therapy. 
Cardiorespiratory sleep study
Since both patientscomplained ofnocturnal snoring, dryness of mouth at the awakening and daytime sleepiness, we decided to perform a cardiorespiratory sleep study to detect the presence of SDB.
For patient 1, the cardiorespiratory sleep study embraced a 6-hour period. 
SLEEP APNEA SYNDROME AND HEART FAILURE
Recent data showed a raising prevalence of SDB in the general population,with moderate to severe SDBaffecting 10% of 30-49-year-old men, 17% of 50-70-year-old men, 3% of 30-49-year-old women and 9% of 50-70 year-old women [4] .The prevalence of SDB might beeven higher among HF patients. Those patients are reported to have a prevalence of OSA ranging from 12 to 53% in polysomnography studies [5, 6, 7] . In addition, more than 55% of patients with OSA have diastolic dysfunction [8] . Numerous studies investigated the prevalence of SDB in the context of HF, reporting inhomogeneous results because of the use of different cutoffs of AHI, variable heart failure severity, dissimilar comorbidities and risk factors between studies.
OSA was found in approximately 11% of 81 ambulatory male patients with systolic HF and a mean EF of 25% [9] . Few years later, the same group prospectively analyzed 100 ambulatory male patients with HF and mean EF of 24% and found a 12% prevalence of OSA. [10] In a similar way Vazir et al [7] found the prevalence of OSA to be 15% among male patients with mild symptomatic HF, and in another prospective study including female patients Wang et al [11] reported a 26% prevalence among 218 heart failure patients with a LVEF lower than 45%. A retrospective study conducted by Sin et al on a larger population of 450 patients with systolic HF showed that 37% of the study population suffered from OSA [12] . In a similar fashion, Ferrier et al found the prevalence of OSA to be 53% in 53 stable HF outpatients [6] . However, the two latter studies used a AHI cutoff of 10/h and included patients with higher EF (anyway remaining below 45%). Further data supported a high OSA prevalence in HF, in fact Oldenburg et al [13] studying 700 HF patients withNew York Heart Association(NYHA) Class ≥ II, found that 36% were affected by OSA based on a AHI cutoff of ≥ 5/h. The same studies also described the prevalence of central sleep apnea (CSA) in patients with chronic HF.
Javaheri et al found CSA prevalence of 40% and 37% in subsequent studies enrolling ambulatory male patients with HF [9, 10] . The studies by Vazir and Wang showed the prevalence of CSA in HF patients to be 38% and 21%, respectively, with the second study also including female patients [7, 11] . In their retrospective study on 450 consecutive patients with systolic HF, Sin et al found a 33% prevalence of CSA [12] , and in a similar way Ferrier et al found a CSA prevalence of 15% [6] . In another study using the minimum AHI cutoff (5/h), CSA prevalence was as high as 40 % (13) . Table 1 provides an overview of the prevalence of OSA and CSA in various studies which enrolled patients with HF.
Those findings altogether point out the importance of SDB in HF patients, despite a dissimilar prevalence in different studies. The basis of such discrepancy might be represented by the use of different cutoff values, dissimilar patient populations in terms of ethnicity and gender prevalence, concomitant presence of both types of apnea and their different classification according to the relative percentage of one of the two types of SDB. Besides, since CSA seems to be associated with more advanced HF, the presence of patients with more severe HF might play an important role as a selection bias in some studies. Recent investigations also showed a high prevalence of SDB, predominantly OSA, among patients with stable HF with NYHA class II-IV and preserved ejection fraction [14] .
PATHOPHYSIOLOGY OF SLEEP APNEA IN THE PRESENCE OF HEART FAILURE
In patients with HF the heart is unable to provide an adequate cardiac output, thus causingincreased fluid retention. A higher prevalence of both obstructive and central sleep apnea, which can coexist in the same subject, has been shown in this population. A recent study hypothesized apossible common pathophysiological pathway underlying both types of apnea in patients with systolic HF [15] . Researchers try to elucidate the complex mechanisms linking the two types of apneic events and HF through three pathways. an increased neck circumference has been observed, which can be related to soft tissues congestion, loss of dilator pharyngeal muscles tone resulting in a pharyngeal obstruction with a consequent and progressive reduction of airflow during nightly breath, thus explaining the occurrence of obstructive apnea events. On the other hand, in patients experiencing central apnea events there is a more pronounced reduction of leg fluid volume which is only partially explained by the increase of neck circumference, suggesting that part of these fluids, concentrating at thoracic level, may be responsible for augmented pulmonary congestion and filling pressures in these patients [15] . Pulmonary congestion is directly related to the pathogenesis of central apnea events through hindered pulmonary gas exchange, characterized by a progressive reduction of PaO2 below the threshold of the physiological nocturnal reduction of 4-10 mmHg and an increase of PaCO2 above the 3-7 mmHg usually observed in a normal sleep. These alterations linked to mechanical strain provoke a stimulation of pulmonary J receptors [16] . The combination of the above mentioned phenomena triggers hyperventilation, subsequently leading to PaCO2 reduction below the so-called apnea threshold, thus suppressing stimulation of the respiratory muscles and causing phases of central apnea. The imbalance of PO2 and PCO2 concentration, caused by both OSA and CSA, stimulates the central nervous system, thus increasing the ventilation rate, provoking arousals with sleep fragmentation and respiratory fatigue with a consequent sleep deprivation; this causes not only an abnormal nightly activation of sympathetic nervous system but also an increased sympathetic tone during the day which is detrimental to a failing heart. (Figure 3 ). The interaction between CSA and HF is therefore complex; fluid retention seems to be a key mechanism linking these two conditions, as also suggested by the recently proven association between excessive sodium intake (with subsequent intra-and extra-vascular plasma volume expansion) and option for patients with sleep apnea also in terms of blood pressure [21, 22] and improved insulin sensitivity [23] . The left ventricular ejection fraction is improved in HF patients when OSA is treated with CPAP [24, 25] .
Although the CANPAP trial failed to show any impact of CPAP on heart transplant-free survival, a post-hoc analysis demonstrated that if CSA is suppressed soon through the use of CPAP, this results in an improvement of both left ventricular ejection fraction and heart transplant-free survival. [26] In patients with chronic HF, OSA and CSA often co-exist; adaptive servoventilation effectively reduced all forms of SDB and improved left ventricular ejection fraction at six-months follow-up in a small study [27] .
LIMITATIONS
We performed the cardiorespiratory sleep studies using a portable monitor. This is the major limitation of the study, since in patients with several comorbid conditions, such as congestive heart failure patients, a complete polysomnography is recommended. However, the use of less expensive and easily available portable monitors for the detection of sleep apneas in heart failure patients has been shown to be an acceptable option by some authors [28] , especially if a relatively high pre-test probability is present, as in our case patients who both complained of typical symptoms.
CONCLUSIONS
In spite of the currently available knowledge about SDB and heart failure, several aspects of the relationship between these two conditions remain unknown. 
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